257
Views
1
CrossRef citations to date
0
Altmetric
Review

Advancements in improving health-related quality of life in patients living with diabetic foot ulcers

, , &
Pages 307-316 | Received 29 Aug 2018, Accepted 24 Oct 2018, Published online: 01 Nov 2018

References

  • Gostin LO, Sridhar D, Hougendobler D. The normative authority of the World Health Organization. Public Health. 2015;129:854–863.
  • Hogg FR, Peach G, Price P, et al. Measures of health-related quality of life in diabetes-related foot disease: a systematic review. Diabetologia. 2012;55:552–565.
  • Wukich DK, Raspovic KM. Assessing health-related quality of life in patients with diabetic foot disease: why is it important and how can we improve? the 2017 roger E. Pecoraro Award Lecture Diabetes Care. 2018;41:391–397.
  • Goodridge D, Trepman E, Sloan J, et al. Quality of life of adults with unhealed and healed diabetic foot ulcers. Foot Ankle Int. 2006;27:274–280.
  • Clouet F, Excler-Cavailher G, Christophe B, et al. Type 2 diabetes and short form 36-items health survey. Diabetes Metab. 2001;27:711–717.
  • Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8:120–129.
  • Lamont P, Franklyn K, Rayman G, et al. Update on the diabetic foot 2012: the 14th biennial Malvern Diabetic Foot Conference, May 9–11,2012. Int J Low Extrem Wounds. 2013;12:71–75.
  • Ribu L, Hanestad BR, Moum T, et al. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16:179–189.
  • Sekhar MS, Thomas RR, Unnikrishnan MK, et al. Impact of diabetic foot ulcer on health-related quality of life: a cross-sectional study. Semin Vasc Surg. 2015;28:165–171.
  • Goodridge D, Trepman E, Embil JM. Health-related quality of life in diabetic patients with foot ulcers: literature review. J Wound Ostomy Continence Nurs. 2005;32:368–377.
  • Wukich DK, Raspovic KM, Suder NC. Patients with diabetic foot disease fear major lower-extremity amputation more than death. Foot Ankle Spec. 2018;11:17–21.
  • Kontodimopoulos N, Veniou A, Tentolouris N, et al. Validity and reliability of the greek version of the diabetic foot ulcer scale - short form (DFS-SF). Hormones (Athens). 2016;15:394–403.
  • Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, et al. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005;48:1906–1910.
  • Brod M. Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res. 1998;7:365–372.
  • Siersma V, Thorsen H, Holstein PE, et al. Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers - the Eurodiale study. J Diabetes Complications. 2017;31:1145–1151.
  • Ribu L, Birkeland K, Hanestad BR, et al. A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: wound healing and quality-of-life changes. J Diabetes Complications. 2008;22:400–407.
  • Kleefstra N, Landman GW, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care. 2008;31:932–933.
  • Crews RT, Shen BJ, Campbell L, et al. and determinants of adherence to off-loading in diabetic foot ulcer healing: a prospective investigation. Diabetes Care. 2016;39:1371–1377.
  • Siersma V, Thorsen H, Holstein PE, et al. Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study. Diabetes Care. 2014;37:694–700.
  • Pickwell KM, Siersma VD, Kars M, et al. Diabetic foot disease: impact of ulcer location on ulcer healing. Diabetes Metab Res Rev. 2013;29:377–383.
  • Braun LR, Fisk WA, Lev-Tov H, et al. Diabetic foot ulcer: an evidence-based treatment update. Am J Clin Dermatol. 2014;15:267–281.
  • Walsh JW, Hoffstad OJ, Sullivan MO, et al. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33:1493–1498.
  • Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the eurodiale study. Diabetologia. 2008;51:1826–1834.
  • Rice JB, Desai U, Cummings AK, et al. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37:651–658.
  • Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther. 2012;3:4.
  • Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:S1–S66.
  • Alavi A, Sibbald RG, Mayer D, et al. Diabetic foot ulcers: part II. management. J Am Acad Dermatol. 2014;70(21):e1–4; quiz 45–6.
  • Buggy A, Moore Z. The impact of the multidisciplinary team in the management of individuals with diabetic foot ulcers: a systematic review. J Wound Care. 2017;26:324–339.
  • Jeffcoate WJ, Price PE, Phillips CJ, et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess. 2009;13:1–86, iii-iv.
  • Wu L, Norman G, Dumville JC, et al. Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews. Cochrane Database Syst Rev. 2015;CD010471.
  • Berlanga-Acosta J. Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment. Int Wound J. 2011;8:612–620.
  • Dinh TL, Veves A. The efficacy of apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006;117:152S-7S; discussion 8S-9S.
  • Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care. 2008;21:568–575.
  • Chadwick P, Acton C. The use of amelogenin protein in the treatment of hard-to-heal wounds. Br J Nurs. 2009;18:S22, S4, S6. passim
  • Ricci E, Cutting KF. Evaluating a native collagen matrix dressing in the treatment of chronic wounds of different aetiologies: a case series. J Wound Care. 2016;25:670–678.
  • Huang Y, Wu M, Xing P, et al. Translation and validation of the Chinese cardiff wound impact schedule. Int J Low Extrem Wounds. 2014;13:5–11.
  • Frykberg RG, Cazzell SM, Arroyo-Rivera J, et al. of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis. J Wound Care. 2016;25(Suppl 7):S18–S25.
  • Whitmont K, McKelvey KJ, Fulcher G, et al. Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial. Int Wound J. 2015;12:422–427.
  • Wang HT, Yuan JQ, Zhang B, et al. Phototherapy for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017;6:CD011979.
  • Sanjeev Kumar G, Panda S, Surya Kumar S. The etiopathogenesis of the diabetic foot: an unrelenting epidemic. Int J Low Extrem Wounds. 2010;9:127–131.
  • Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2013;CD002302.
  • Bus SA, van Deursen RW, Armstrong DG, et al. and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(Suppl 1):99–118.
  • Caravaggi C, Faglia E, De Giglio R, et al. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care. 2000;23:1746–1751.
  • Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. baseline results from the eurodiale study. Diabetologia. 2007;50:18–25.
  • Armstrong DG, Lavery LA, Wrobel JS, et al. Quality of life in healing diabetic wounds: does the end justify the means? J Foot Ankle Surg. 2008;47:278–282.
  • Burns J, Wegener C, Begg L, et al. Randomized trial of custom orthoses and footwear on foot pain and plantar pressure in diabetic peripheral arterial disease. Diabet Med. 2009;26:893–899.
  • Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med. 1998;15:412–417.
  • Piaggesi A, Macchiarini S, Rizzo L, et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care. 2007;30:586–590.
  • Piaggesi A, Goretti C, Iacopi E, et al. Comparison of removable and irremovable walking boot to total contact casting in offloading the neuropathic diabetic foot ulceration. Foot Ankle Int. 2016;37:855–861.
  • Jeffcoate W, Game F, Turtle-Savage V, et al. Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial. Health Technol Assess. 2017;21:1–92.
  • Health Quality O. fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: a health technology assessment. Ont Health Technol Assess Ser. 2017;17:1–124.
  • Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010;CD003556.
  • Tian X, Liang XM, Song GM, et al. Maggot debridement therapy for the treatment of diabetic foot ulcers: a meta-analysis. J Wound Care. 2013;22:462–469.
  • Somayaji R, Elliott JA, Persaud R, et al. The impact of team based interprofessional comprehensive assessments on the diagnosis and management of diabetic foot ulcers: A retrospective cohort study. PLoS One. 2017;12:e0185251.
  • Ogrin R, Houghton PE, Thompson GW. Effective management of patients with diabetes foot ulcers: outcomes of an interprofessional diabetes foot ulcer team. Int Wound J. 2015;12:377–386.
  • Rerkasem K, Kosachunhanun N, Tongprasert S, et al. A multidisciplinary diabetic foot protocol at chiang mai university hospital: cost and quality of life. Int J Low Extrem Wounds. 2009;8:153–156.
  • American Diabetes. Microvascular complications and foot care: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S105–S18.
  • Gao J, Wang J, Zheng P, et al. Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC Fam Pract. 2013;14:66.
  • Walker RJ, Smalls BL, Hernandez-Tejada MA, et al. Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethn Dis. 2014;24:349–355.
  • Bonner T, Foster M, Spears-Lanoix E. Type 2 diabetes-related foot care knowledge and foot self-care practice interventions in the United States: a systematic review of the literature. Diabet Foot Ankle. 2016;7:29758.
  • Cochran J, Conn VS. Meta-analysis of quality of life outcomes following diabetes self-management training. Diabetes Educ. 2008;34:815–823.
  • McBride E, Hacking B, O’Carroll R, et al. Increasing patient involvement in the diabetic foot pathway: a pilot randomized controlled trial. Diabet Med. 2016;33:1483–1492.
  • Lincoln NB, Radford KA, Game FL, et al. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia. 2008;51:1954–1961.
  • Miraj SS, Roy RT, Unnikrishnan M, et al. Effect of patient-education on health-related quality of life of diabetic foot ulcer patients in a tertiarycare hospital. Value Health. 2015;18:A621.
  • Sharoni SKA, Abdul Rahman H, Minhat HS, et al. A self-efficacy education programme on foot self-care behaviour among older patients with diabetes in a public long-term care institution, Malaysia: a quasi-experimental pilot study. BMJ Open. 2017;7:e014393.
  • Hazenberg CE, Bus SA, Kottink AI, et al. Telemedical home-monitoring of diabetic foot disease using photographic foot imaging–a feasibility study. J Telemed Telecare. 2012;18:32–36.
  • Lavery LA, Higgins KR, Lanctot DR, et al. monitoring of foot skin temperatures to prevent ulceration. Diabetes Care. 2004;27:2642–2647.
  • Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26:491–494.
  • Boutoille D, Feraille A, Maulaz D, et al. Quality of life with diabetes-associated foot complications: comparison between lower-limb amputation and chronic foot ulceration. Foot Ankle Int. 2008;29:1074–1078.
  • Pickwell K, Siersma V, Kars M, et al. amputation does not negatively affect health-related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: an observational study. Diabetes Metab Res Rev. 2017;33:e2867.
  • Wukich DK, Raspovic KM. What role does function play in deciding on limb salvage versus amputation in patients with diabetes? Plast Reconstr Surg. 2016;138:188S–95S.
  • Wukich DK, Ahn J, Raspovic KM, et al. Improved quality of life after transtibial amputation in patients with diabetes-related foot complications. Int J Low Extrem Wounds. 2017;16:114–121.
  • Willrich A, Pinzur M, McNeil M, et al. Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study. Foot Ankle Int. 2005;26:128–134.
  • Attinger CE, Brown BJ. Amputation and ambulation in diabetic patients: function is the goal. Diabetes Metab Res Rev. 2012;28(Suppl 1):93–96.
  • Stoekenbroek RM, Santema TB, Legemate DA, et al. Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg. 2014;47:647–655.
  • Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;CD004123.
  • Lin LC, Yau G, Lin TF, et al. The efficacy of hyperbaric oxygen therapy in improving the quality of life in patients with problem wounds. J Nurs Res. 2006;14:219–227.
  • Chen CY, Wu RW, Hsu MC, et al. Adjunctive hyperbaric oxygen therapy for healing of chronic diabetic foot ulcers: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2017;44:536–545.
  • Londahl M, Landin-Olsson M, Katzman P. Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabet Med. 2011;28:186–190.
  • Li G, Hopkins RB, Levine MAH, et al. Relationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial. Acta Diabetol. 2017;54:823–831.
  • Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg. 2003;25:513–518.
  • Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235–241.
  • Katarina H, Magnus L, Per K, et al. Diabetic persons with foot ulcers and their perceptions of hyperbaric oxygen chamber therapy. J Clin Nurs. 2009;18:1975–1985.
  • Wu SC, Armstrong DG. Clinical outcome of diabetic foot ulcers treated with negative pressure wound therapy and the transition from acute care to home care. Int Wound J. 2008;5(Suppl 2):10–16.
  • Pham CT, Middleton PF, Maddern GJ. The safety and efficacy of topical negative pressure in non-healing wounds: a systematic review. J Wound Care. 2006;15:240–250.
  • Ubbink DT, Westerbos SJ, Nelson EA, et al. A systematic review of topical negative pressure therapy for acute and chronic wounds. Br J Surg. 2008;95:685–692.
  • Karatepe O, Eken I, Acet E, et al. Vacuum assisted closure improves the quality of life in patients with diabetic foot. Acta Chir Belg. 2011;111:298–302.
  • Ousey KJ, Milne J, Cook L, et al. A pilot study exploring quality of life experienced by patients undergoing negative-pressure wound therapy as part of their wound care treatment compared to patients receiving standard wound care. Int Wound J. 2014;11:357–365.
  • Mendonca DA, Drew PJ, Harding KG, et al. A pilot study on the effect of topical negative pressure on quality of life. J Wound Care. 2007;16:49–53.
  • Janssen AH, Mommers EH, Notter J, et al. Negative pressure wound therapy versus standard wound care on quality of life: a systematic review. J Wound Care. 2016;25(154):6–9.
  • Upton D, Stephens D, Andrews A. Patients’ experiences of negative pressure wound therapy for the treatment of wounds: a review. J Wound Care. 2013;22:34–39.
  • Abbotts J. Patients’ views on topical negative pressure: ‘effective but smelly’. Br J Nurs. 2010;19:S37–S41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.